STRUCTURAL-PROPERTIES AND MUTATION PATTERNS OF ANTI-NUCLEOSOME MONOCLONAL-ANTIBODIES ARE SIMILAR TO THOSE OF ANTI-DNA ANTIBODIES

Citation
F. Brard et al., STRUCTURAL-PROPERTIES AND MUTATION PATTERNS OF ANTI-NUCLEOSOME MONOCLONAL-ANTIBODIES ARE SIMILAR TO THOSE OF ANTI-DNA ANTIBODIES, European Journal of Immunology, 26(7), 1996, pp. 1587-1594
Citations number
38
Categorie Soggetti
Immunology
ISSN journal
00142980
Volume
26
Issue
7
Year of publication
1996
Pages
1587 - 1594
Database
ISI
SICI code
0014-2980(1996)26:7<1587:SAMPOA>2.0.ZU;2-I
Abstract
Four monoclonal antibodies (mAb) derived from an (NZB x NZW)F1 mouse b ound to nucleosomes, total histones and to the H2A-H2B dimers but not to individual histones or DNA. Sequencing of their heavy (H)- and ligh t (L)-chain variable region genes showed that they derived by somatic mutations from the same B cell precursor. The distribution of negative ly and positively charged amino acids in the H-chain complementarity-d etermining regions was very similar to that observed not only in anti- H2A-H2B mAb derived from different lupus-prone mouse strains but also in anti-DNA mAb. Combined analysis of the mAb structures and their int eractions with immobilized H2A-H2B dimer or total histones by plasmon resonance allowed us to assign the H-chain mutations a major role in t he binding profiles of these anti-nucleosome mAb. Interestingly, four of the five H-chain mutations that distinguished mAb 3F6 from 2E1 gene rated negatively or positively charged amino acid residues, and two of them occurred at positions 56 and 76, which are frequently involved i n the maturation process of anti-DNA antibodies. A modeling study of t he 3F6 variable fragment (Fv) predicted that acidic residues occupy th e cleft of the Ab combining site and have the potential to participate in electrostatic interactions. Thus, the demonstration that (NZB x NZ W)F1-derived anti-H2A-H2B antibodies share certain structural features and mutation patterns with anti-DNA mAb suggest that common selection and maturation processes account for the production of these lupus-re lated autoantibodies.